Literature DB >> 24668276

Prognostic imaging of neuroblastoma.

Anna-Liisa Brownell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24668276     DOI： 10.1007/s00259-014-2749-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

2.  Localization of intracranial lesions by scanning with positron-emitting arsenic.

Authors:  W H SWEET; G L BROWNELL
Journal:  J Am Med Assoc       Date:  1955-04-02

3.  18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.

Authors:  Egesta Lopci; Arnoldo Piccardo; Cristina Nanni; Vania Altrinetti; Alberto Garaventa; Andrea Pession; Angelina Cistaro; Arturo Chiti; Giampiero Villavecchia; Stefano Fanti
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

4.  Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Egesta Lopci; Massimo Conte; Luca Foppiani; Stefania Sorrentino; Giovanni Morana; Mehrdad Naseri; Angelina Cistaro; Giampiero Villavecchia; Stefano Fanti; Alberto Garaventa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

5.  ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Authors:  Henriette Ingrid Melzer; Eva Coppenrath; Irene Schmid; Michael H Albert; Dietrich von Schweinitz; Coral Tudball; Peter Bartenstein; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-27       Impact factor: 9.236

Review 6.  Pediatrics: diagnosis of neuroblastoma.

Authors:  Susan E Sharp; Michael J Gelfand; Barry L Shulkin
Journal:  Semin Nucl Med       Date:  2011-09       Impact factor: 4.446

Review 7.  Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Authors:  Wolfgang Peter Mueller; Eva Coppenrath; Thomas Pfluger
Journal:  Pediatr Radiol       Date:  2012-11-14

8.  Characterization of neuroblastic tumors using 18F-FDOPA PET.

Authors:  Meng-Yao Lu; Yen-Lin Liu; Hsiu-Hao Chang; Shiann-Tarng Jou; Yung-Li Yang; Kai-Hsin Lin; Dong-Tsamn Lin; Ya-Ling Lee; Hsinyu Lee; Pei-Yi Wu; Tsai-Yueh Luo; Lie-Hang Shen; Shiu-Feng Huang; Yung-Feng Liao; Wen-Ming Hsu; Kai-Yuan Tzen
Journal:  J Nucl Med       Date:  2012-12-04       Impact factor: 10.057

9.  Diagnostic value of combined ¹⁸F-FDG PET/MRI for staging and restaging in paediatric oncology.

Authors:  Thomas Pfluger; Henriette I Melzer; Wolfgang P Mueller; Eva Coppenrath; Peter Bartenstein; Michael H Albert; Irene Schmid
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-28       Impact factor: 9.236

Review 10.  Promising therapeutic targets in neuroblastoma.

Authors:  Katherine K Matthay; Rani E George; Alice L Yu
Journal:  Clin Cancer Res       Date:  2012-05-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.